Zydus Lifesciences gets four observations in USFDA inspection of Himachal Pradesh's Baddi plant
The inspection was carried out from August 4 to August 13, 2025. The company said the inspection ended with four observations, with no data integrity-related remarks. Shares of Zydus Lifesciences Ltd ended at ₹989.05, up by ₹32.95, or 3.45%, on the BSE.

What's Your Reaction?






